Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: A population-based study

Journal of Vascular Surgery

Volumn 38, Issue 2, 2003, Pages 279-288

  Al Omran, Mohammed ^a,b,c   Tu, Jack V ^a,b,c,d   Johnston, K Wayne ^a,c,e   Mamdani, Muhammad M ^a,b   Kucey, Daryl S ^a,b,c,d  

^a University of Toronto ^*

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPUTATION; ARTERY BYPASS; ARTICLE; CANADA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; BLOOD VESSEL TRANSPLANTATION; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PERIPHERAL VASCULAR DISEASE; PROPORTIONAL HAZARDS MODEL; STATISTICS; SURVIVAL;

AMPUTATION; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0041384180     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00274-X     Document Type: Article

References (50)

1. TASC Working Group. Management of peripheral arterial disease (PAD). Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(suppl 1, part 2):S1-288.
2. Maini BS, Mannick JA. Effect of arterial reconstruction on limb salvage: a ten-year appraisal. Arch Surg 1978;113:1297-1304.
3. Codd JE, et al. Extremity revascularization: a decade of experience. Am J Surg 1979;138:770-6.
4. Mattes E, Norman PE, Jamrozik K. Falling incidence of amputations for peripheral occlusive arterial disease in western Australia between 1980 and 1992. Eur J Vasc Endovasc Surg 1997;13:14-22.
5. Feinglass J, et al. Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996. Am J Publ Health 1999;89:1222-7.
6. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. N Engl J Med 1991;325:556-62.
7. Sayers RD, Thompson MM, Varty K, Jagger C, Bell PR. Effects of the development of modern vascular services on amputation rates in Leicester, U.K.: a preliminary report. Ann Vasc Surg 1993;7:102-5.
8. Ebskov LB, Schroeder TV, Holstein PE. Epidemiology of leg amputation: the influence of vascular surgery. Br J Surg 1994;81:1600-3.
9. Hallett JW Jr, et al. Impact of arterial surgery and balloon angioplasty on amputation: a population-based study of 1155 procedures between 1973 and 1992. J Vasc Surg 1997;25:29-38.
10. Pell JP, et al. Declining incidence of amputation for arterial disease in Scotland. Eur J Vasc Surg 1994;8:602-6.
11. US National Center for Health Statistics. International classification of disease. 9th rev. Clinical modification. Vols 1-3. Ann Arbor, Mich: Commission on Professional and Hospital Activites; 1986.
12. Canadian classification of diagnostic, therapeutic, and surgical procedures. Ottawa, Ont: Statistics Canada; 1986.
13. Ontario Ministry of Health. Schedule of benefits: physician services under the Health Insurance Act; 1992.
14. Kaplan EL, Meier P. Nonparameteric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Katz MH, Hauck WW. Proportional hazards (Cox) regression. J Gen Intern Med 1993;8:702-11.
16. Kleinbaum DG. Survival analysis: a self-learning text. New York: Springer-Verlag; 1996.
17. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 1999;12:123-37.
18. Nehler MR, Taylor LM, Moneta GL, Porter JM. Natural history, nonoperative treatment, and functional assessment in chronic lower extremity ischemia. In: Moore WS, editor. Vascular surgery: a comprehensive review. 5th ed. Philadelphia: WB Saunders; 1998. p 251-65.
19. Malone JM, Moore WS, Goldstone J. Life expectancy following aorto-femoral arterial grafting. Surgery 1977;81:551-5.
20. Nevelsteen A, Suy R, Daenen W, Boel A, Stalpaert G. Aortofemoral grafting: factors influencing late results. Surgery 1980;88:642-53.
21. Satiani B, Liapis CD, Evans WE. Aortofemoral bypass for severe limb ischemia: long-term survival and limb salvage. Am J Surg 1981;141: 252-6.
22. Crawford ES, Bomberger RA, Glaeser DH, Saleh SA, Russell WL. Aortoiliac occlusive disease: factors influencing survival and function following reconstructive operation over a twenty-five-year period. Surgery 1981;90:1055-67.
23. Sanchez LA, Veith FJ. Femoral-popliteal-tibial occlusive disease. In: Moore WS, editor. Vascular surgery: a comprehensive review. 5th ed. Philadelphia: WB Saunders, 1998; 497-520.
24. Kram HB, et al. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments. J Vasc Surg 1991;14: 386-90.
25. Byrne J, et al. Infrainguinal arterial reconstruction for claudication: is it worth the risk? An analysis of 409 procedures. J Vasc Surg 1999;29: 259-67.
26. Banerjee AK, et al. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost 1992;68:261-3.
27. Faulkner KW, House AK. Comparative survival rates in symptomatic peripheral vascular disease and colorectal cancer. Aust NZ J Surg 1981;51:152-6.
28. Cheng SW, Ting AC, Lau H, Wong J. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg 2000;14: 158-65.
29. Hooi JD, Stoffers HE, Knottnerus JA, van Ree JW. The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence. Br J Gen Pract 1999;49:49-55.
30. Dormandy JA, Murray GD. The fate of the claudicant: a prospective study of 1969 claudicants. Eur J Vasc Surg 1991;5:131-3.
31. De Wess JA, Rob CG. Autogenous vein grafts ten years later. Surgery 1962;6:775-84.
32. Szilagyi DE, Elliott JP Jr, Smith RF, Reddy DJ, McPharlin M. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J Vasc Surg 1986;3:421-36.
33. Jelnes R, et al. Fate in intermittent claudication: outcome and risk factors. Br Med J 1986;293:1137-40.
34. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication. The Framingham Study. J Am Geriatr Soc 1985;33:13-8.
35. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979;241:2035-8.
36. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994;1:333-9.
37. Fowkes FG, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
38. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 1997;96:44-9.
39. Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham Study. JAMA 1972;221:661-6.
40. Beach KW, Brunzell JD, Strandness DE Jr. Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus: relation to smoking and form of therapy. Arteriosclerosis 1982;2:275-80.
41. Melton LJ III, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980;3:650-4.
42. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 1981;34:261-9.
43. Gofin R, et al. Peripheral vascular disease in a middle-aged population sample. The Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci 1987;23:157-67.
44. Criqui MH, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989;129:1110-9.
45. Da Silva A, Widmer LK, Ziegler HW, Nissen C, Schweizer W. Report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. The Basel Longitudinal Study. J Chronic Dis 1979;32:797-803.
46. Liedberg E, Persson BM. Age, diabetes and smoking in lower limb amputation for arterial occlusive disease. Acta Orthop Scand 1983;54: 383-8.
47. Eickhoff JH, Hansen HJ, Lorentzen JE. The effect of arterial reconstruction on lower limb amputation rate: an epidemiological survey based on reports from Danish hospitals. Acta Chir Scand Suppl 1980; 502:181-7.
48. Lassen N, et al. Conservative treatment of gangrene using mineralocorticoid-induced moderate hypertension. Lancet 1968;1:606-9.
49. Williams JI, Young W. Inventory of studies on the accuracy of Canadian health administrative databases. 96-03-TR. Toronto, Ont: Institute of Clinical Evaluative Sciences; 1996.
50. Tarry W, et al. Fate of the contralateral leg after infrainguinal bypass. J Vasc Surg 1998;27:1039-48.